Das, J., O'Connor, T. F., Fisher, A. C., Osorio, M., Lam, J., & Myers, R. C. (2025). Public feedback to FDA on regulatory considerations for AI in drug manufacturing. AAPS Open, 11(1), 1. https://doi.org/10.1186/s41120-025-00110-w
Chicago Style (17th ed.) CitationDas, Jayanti, Thomas F. O'Connor, Adam C. Fisher, Manuel Osorio, Johnny Lam, and Riley C. Myers. "Public Feedback to FDA on Regulatory Considerations for AI in Drug Manufacturing." AAPS Open 11, no. 1 (2025): 1. https://doi.org/10.1186/s41120-025-00110-w.
MLA (9th ed.) CitationDas, Jayanti, et al. "Public Feedback to FDA on Regulatory Considerations for AI in Drug Manufacturing." AAPS Open, vol. 11, no. 1, 2025, p. 1, https://doi.org/10.1186/s41120-025-00110-w.
Warning: These citations may not always be 100% accurate.